OKYO Pharma Limited (OKYO)

NASDAQ: OKYO · IEX Real-Time Price · USD
2.17
+0.05 (2.36%)
At close: Aug 8, 2022 3:59 PM
2.19
+0.02 (0.69%)
After-hours: Aug 8, 2022 6:32 PM EDT

Income Statement (Trailing)

Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Quarter Ending 2021-09-302021-03-312020-03-31
Selling, General & Admin
4.933.191.02
Research & Development
0.620.170.52
Operating Expenses
5.543.371.53
Operating Income
-5.54-3.37-1.53
Interest Expense / Income
000
Other Expense / Income
-0.060.010.08
Pretax Income
-5.49-3.38-1.62
Income Tax
-0.21-0.02-0.08
Net Income
-5.27-3.35-1.54
Net Income Common
-5.27-3.35-1.54
Shares Outstanding (Basic)
1,4071,407-
EPS (Basic)
-0.65-0.65-
EPS (Diluted)
-0.65-0.65-
Free Cash Flow Per Share
-0.19-0.07-
Effective Tax Rate
3.90%0.74%4.71%
EBITDA
-5.46-3.37-1.61
Depreciation & Amortization
0.030.010.01
EBIT
-5.49-3.38-1.62
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).